Skip to content
2000
image of Meta-analysis and Database Validation of Exosomal microRNAs and Prognosis in Gastric Cancer Patients

Abstract

Background

Exosomal microRNAs (miRNAs) have been identified as pivotal regulators in the progression of diverse oncogenic processes. However, the relationship between exosomal miRNAs and the clinicopathological characteristics of gastric cancer (GC) patients remains a subject of debate. The present study was designed to meticulously assess the link between exosomal miRNAs and GC through a meticulous meta-analysis and rigorous database validation.

Methods

The case-control studies about the relationship between exosomal miRNAs and GC were retrieved from CNKI, SinoMed, Embase, Web of Science, the Cochrane Library and PubMed database. The retrieval time was from inception to November, 2023. Two researchers independently screened the literature, extracted the data and evaluated the quality of the included studies. The meta-analysis of the included literature was conducted by the Stata 12.0 software. The database of Kaplan-Meier plotter predicted that the expression of miRNA was correlated with prognostic value in GC patients. The study protocol has been registered in PROSPERO (CRD42023490351).

Results

A total of 24 studies, involving 3490 participants, were included in this analysis. The meta-analysis results indicated that there was no significant decrease in the incidence of clinicopathological parameters associated with exosomal miRNAs in GC patients. However, analysis of the Kaplan-Meier plotter database revealed that high expression levels of hsa-mir-134, hsa-mir-100, hsa-mir-552, hsa-mir-30a, and hsa-mir-23b were associated with poor prognosis in GC patients, with hazard ratios (HRs) of 1.45 (95% confidence interval [CI]: 1.06-1.99, =0.021), 1.67 (95% : 1.23-2.27, =0.00098), 1.63 (95% : 1.11-2.40, =0.012), 1.56 (95% : 1.08-2.26, =0.017), and 1.52 (95% : 1.12-2.06, =0.0066), respectively.

Conclusion

These findings align with prior studies highlighting the role of specific miRNAs in tumor progression but diverge regarding their diagnostic utility for clinicopathological features. Future research should explore the functional mechanisms of these miRNAs in GC biology and validate their prognostic value in larger, diverse cohorts to inform personalized treatment strategies.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673356200250612183707
2025-07-29
2025-11-04

  • From This Site

    /content/journals/cmc/10.2174/0109298673356200250612183707
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Smyth E.C. Nilsson M. Grabsch H.I. van Grieken N.C. Lordick F. Gastric cancer. Lancet 2020 396 10251 635 648 10.1016/S0140‑6736(20)31288‑5 32861308
    [Google Scholar]
  2. Huang C. Zhou Y. Feng X. Wang J. Li Y. Yao X. Delivery of engineered primary tumor-derived exosomes effectively suppressed the colorectal cancer chemoresistance and liver metastasis. ACS Nano 2023 17 11 10313 10326 10.1021/acsnano.3c00668 37141393
    [Google Scholar]
  3. Wu C. Hou X. Li S. Wang J. Luo S. Identification of a potential competing endogenous RNA (ceRNA) network in gastric adenocarcinoma. J. Gastrointest. Oncol. 2023 14 2 1019 1036 10.21037/jgo‑22‑1201 37201096
    [Google Scholar]
  4. Hsu C.C. Yang Y. Kannisto E. Zeng X. Yu G. Patnaik S.K. Dy G.K. Reid M.E. Gan Q. Wu Y. Simultaneous detection of tumor derived exosomal protein–MicroRNA pairs with an exo-PROS biosensor for cancer diagnosis. ACS Nano 2023 17 9 8108 8122 10.1021/acsnano.2c10970 37129374
    [Google Scholar]
  5. Yu H. Pan J. Zheng S. Cai D. Luo A. Xia Z. Huang J. Hepatocellular carcinoma cell-derived exosomal miR-21-5p induces macrophage M2 polarization by targeting RhoB. Int. J. Mol. Sci. 2023 24 5 4593 10.3390/ijms24054593 36902024
    [Google Scholar]
  6. Thapa N. Chwae Y. Yoo K. Won T.B. Kang D. Choi D. Kim J. Exosomal delivery of TRAIL and miR‑335 for the treatment of hepatocellular carcinoma (Review). Int. J. Mol. Med. 2022 51 1 3 10.3892/ijmm.2022.5206 36416311
    [Google Scholar]
  7. Hao C. Sheng Z. Wang W. Feng R. Zheng Y. Xiao Q. Zhang B. Tumor‐derived exosomal MIR ‐148b‐3p mediates M2 macrophage polarization via TSC2 / MTORC1 to promote breast cancer migration and invasion. Thorac. Cancer 2023 14 16 1477 1491 10.1111/1759‑7714.14891 37144254
    [Google Scholar]
  8. Hsu X.R. Wu J.E. Wu Y.Y. Hsiao S.Y. Liang J.L. Wu Y.J. Tung C.H. Huang M.F. Lin M.S. Yang P.C. Chen Y.L. Hong T.M. Exosomal long noncoding RNA MLETA1 promotes tumor progression and metastasis by regulating the miR-186-5p/EGFR and miR-497-5p/IGF1R axes in non-small cell lung cancer. J. Exp. Clin. Cancer Res. 2023 42 1 283 10.1186/s13046‑023‑02859‑y 37880793
    [Google Scholar]
  9. Zhang X. Hou H. Jiang M. Zhang X. Aberrant circulating tumor DNA methylation and exosomal microRNA biomarkers for early detection of colorectal cancer. Mol. Biol. Rep. 2023 50 3 2743 2750 10.1007/s11033‑022‑08194‑3 36583782
    [Google Scholar]
  10. Hong F. Li N. Feng Z. Zheng Y. Zhu C. Zhang F. Exosomal microRNAs as novel diagnostic biomarkers in breast cancer: A systematic evaluation and meta-analysis. Asian J. Surg. 2023 46 11 4727 4736 10.1016/j.asjsur.2023.05.115 37301624
    [Google Scholar]
  11. Qiu S. Xie L. Lu C. Gu C. Xia Y. Lv J. Xuan Z. Fang L. Yang J. Zhang L. Li Z. Wang W. Xu H. Li B. Xu Z. Gastric cancer-derived exosomal miR-519a-3p promotes liver metastasis by inducing intrahepatic M2-like macrophage-mediated angiogenesis. J. Exp. Clin. Cancer Res. 2022 41 1 296 10.1186/s13046‑022‑02499‑8 36217165
    [Google Scholar]
  12. Xie M. Yu T. Jing X. Ma L. Fan Y. Yang F. Ma P. Jiang H. Wu X. Shu Y. Xu T. Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p/HUR/VEGF axis and suppressing HSP90 degradation. Mol. Cancer 2020 19 1 112 10.1186/s12943‑020‑01208‑3 32600329
    [Google Scholar]
  13. Li Z. Liu Z.M. Xu B.H. A meta-analysis of the effect of microRNA-34a on the progression and prognosis of gastric cancer. Eur. Rev. Med. Pharmacol. Sci. 2018 22 23 8281 8287 30556868
    [Google Scholar]
  14. Ye H. Zhu W. Mei L. Lu Z. Prognostic and clinicopathologic significance of MicroRNA-125a-5p in cancers. Medicine 2019 98 31 e16685 10.1097/MD.0000000000016685 31374052
    [Google Scholar]
  15. Liang T. Wang J. Zhu C. Hu Y. Gao Z. Da M. Prognosis and clinical significance of Piezo2 in tumor: A meta-analysis and database validation. Comb. Chem. High Throughput Screen. 2024 27 19 2912 2920 10.2174/0113862073251440231025111358 38347800
    [Google Scholar]
  16. Delgado-Rodríguez M. Sillero-Arenas M. Systematic review and meta-analysis. Med. Intensiva 2018 42 7 444 453 10.1016/j.medine.2017.10.012 29169792
    [Google Scholar]
  17. Yang J.J. Dang Y.N. Peng L. Jin D.C. Sang H.M. Chen M.H. Zhang G.X. The efficacy of miR-452 in plasma exosomes as a biomarker for the diagnosis of gastric cancer. Chin. J. Gastroenterol. Hepatol. 2019 28 09 1023 1029 https://kns.cnki.net/kcms2/article/abstract?v=gHWJqxSIlt0JcP9bVsxhZtAgUOadjTJp3cLwqqhLl7-gyVotXRYDg44MWhLmg27mNWN0SRHHciSB1d_0tdtQZVUOptB4zppcuyLOMJI2r6aolbP9YDi8Uz03birrxX8Or2PNWDQiCVot-bbt6XZSUjN1XfcpAH3x5m37en-R_c-xVEFUHMRSDOoTYkN0j41s4-X-IIb1tGrOw=&uniplatform=NZKPT&language=CHS
    [Google Scholar]
  18. Wang X.Y. Yu T. Zhang J. Teng L. Cai W. Huang K.Y. Ji J.T. Wu Y. Du T.M. Wang Z.H. Han L. Wang H. Expression and clinical significance of microRNA-374a-5p in exosomes from gastric cancer. Chin. J. Exp. Surg. 2021 38 07 1336 1339 https://rs.yiigle.com/cmaid/1328428
    [Google Scholar]
  19. You HH Ding Y Zhou YL Expression of serum exosomal miRNA-21 and its clinical significance in gastric cancer. Chin. J. Gen. Surg. 2020 12 223 227 https://rs.yiigle.com/cmaid/1191115
    [Google Scholar]
  20. Zhang X.C. Wang L. Zhao X.L. Tian X.P. Lei Q.X. Liu D.X. Expression and significance of exosomal microRNA-181-5p in gastric cancer. Chin. J. Exp. Surg. 2021 38 08 1578 1580 https://rs.yiigle.com/cmaid/1330363
    [Google Scholar]
  21. Li Q. Li B. Li Q. Wei S. He Z. Huang X. Wang L. Xia Y. Xu Z. Li Z. Wang W. Yang L. Zhang D. Xu Z. Exosomal miR-21-5p derived from gastric cancer promotes peritoneal metastasis via mesothelial-to-mesenchymal transition. Cell Death Dis. 2018 9 9 854 10.1038/s41419‑018‑0928‑8 30154401
    [Google Scholar]
  22. Shi Y. Wang Z. Zhu X. Chen L. Ma Y. Wang J. Yang X. Liu Z. Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer. Int. J. Clin. Oncol. 2020 25 1 89 99 10.1007/s10147‑019‑01532‑9 31506750
    [Google Scholar]
  23. Zhang J. Qiu W. Zhu H. Liu H. Sun J. Chen Y. Shen H. Qian C. Shen Z. HOTAIR contributes to the carcinogenesis of gastric cancer via modulating cellular and exosomal miRNAs level. Cell Death Dis. 2020 11 9 780 10.1038/s41419‑020‑02946‑4 32951010
    [Google Scholar]
  24. Imamura T. Komatsu S. Ichikawa D. Miyamae M. Okajima W. Ohashi T. Kiuchi J. Nishibeppu K. Kosuga T. Konishi H. Shiozaki A. Okamoto K. Fujiwara H. Otsuji E. Low plasma levels of miR-101 are associated with tumor progression in gastric cancer. Oncotarget 2017 8 63 106538 106550 10.18632/oncotarget.20860 29290969
    [Google Scholar]
  25. Wei S. Peng L. Yang J. Sang H. Jin D. Li X. Chen M. Zhang W. Dang Y. Zhang G. Exosomal transfer of miR-15b-3p enhances tumorigenesis and malignant transformation through the DYNLT1/Caspase-3/Caspase-9 signaling pathway in gastric cancer. J. Exp. Clin. Cancer Res. 2020 39 1 32 10.1186/s13046‑019‑1511‑6 32039741
    [Google Scholar]
  26. Du J. Liang Y. Li J. Zhao J.M. Lin X.Y. Gastric cancer cell-derived exosomal microRNA-23a promotes angiogenesis by targeting PTEN. Front. Oncol. 2020 10 326 10.3389/fonc.2020.00326 32232005
    [Google Scholar]
  27. Kumata Y. Iinuma H. Suzuki Y. Tsukahara D. Midorikawa H. Igarashi Y. Soeda N. Kiyokawa T. Horikawa M. Fukushima R. Exosome‑encapsulated microRNA‑23b as a minimally invasive liquid biomarker for the prediction of recurrence and prognosis of gastric cancer patients in each tumor stage. Oncol. Rep. 2018 40 1 319 330 10.3892/or.2018.6418 29749537
    [Google Scholar]
  28. Lu X. Lu J. Wang S. Zhang Y. Ding Y. Shen X. Jing R. Ju S. Chen H. Cong H. Circulating serum exosomal miR-92a-3p as a novel biomarker for early diagnosis of gastric cancer. Future Oncol. 2021 17 8 907 919 10.2217/fon‑2020‑0792 33533649
    [Google Scholar]
  29. Zhang Y. Meng W. Yue P. Li X. RETRACTED ARTICLE: M2 macrophage-derived extracellular vesicles promote gastric cancer progression via a microRNA-130b-3p/MLL3/GRHL2 signaling cascade. J. Exp. Clin. Cancer Res. 2020 39 1 134 10.1186/s13046‑020‑01626‑7 32660626
    [Google Scholar]
  30. Zhang X. Wang S. Wang H. Cao J. Huang X. Chen Z. Xu P. Sun G. Xu J. Lv J. Xu Z. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway. Mol. Cancer 2019 18 1 20 10.1186/s12943‑018‑0935‑5 30717751
    [Google Scholar]
  31. Zhang Y. Huang F. Xu N. Wang J. Li D. Yin L. Overexpression of serum extracellular vesicle microRNA-215-5p is associated with early tumor recurrence and poor prognosis of gastric cancer. Clinics 2021 76 e2081 10.6061/clinics/2021/e2081 33978071
    [Google Scholar]
  32. Ji R. Zhang X. Gu H. Ma J. Wen X. Zhou J. Qian H. Xu W. Qian J. Lin J. miR-374a-5p: A new target for diagnosis and drug resistance therapy in gastric cancer. Mol. Ther. Nucleic Acids 2019 18 320 331 10.1016/j.omtn.2019.07.025 31614322
    [Google Scholar]
  33. Chang L. Gao H. Wang L. Wang N. Zhang S. Zhou X. Yang H. Exosomes derived from miR-1228 overexpressing bone marrow-mesenchymal stem cells promote growth of gastric cancer cells. Aging 2021 13 8 11808 11821 10.18632/aging.202878 33883305
    [Google Scholar]
  34. Soeda N. Iinuma H. Suzuki Y. Tsukahara D. Midorikawa H. Igarashi Y. Kumata Y. Horikawa M. Kiyokawa T. Fukagawa T. Fukushima R. Plasma exosome‑encapsulated microRNA‑21 and microRNA‑92a are promising biomarkers for the prediction of peritoneal recurrence in patients with gastric cancer. Oncol. Lett. 2019 18 5 4467 4480 10.3892/ol.2019.10807 31611956
    [Google Scholar]
  35. Zheng G.D. Xu Z.Y. Hu C. Lv H. Xie H.X. Huang T. Zhang Y.Q. Chen G.P. Fu Y.F. Cheng X.D. Exosomal miR-590-5p in serum as a biomarker for the diagnosis and prognosis of gastric cancer. Front. Mol. Biosci. 2021 8 636566 10.3389/fmolb.2021.636566 33681295
    [Google Scholar]
  36. Zheng Z.H. Xu C.J. Effects of exosome miR-552 expression on biological behavior of gastric cancer and its clinical significance. J. Med. Forum. 2021 42 19 102 105 https://kns.cnki.net/kcms2/article/abstract?v=gHWJqxSIlt3bwpJ8e9__kBPU4MsaWsdJU2DvViUFeoN2-pas0dUyZPsVDGUQqjLQ5zuTrG5lqVT152VpXxANOuitm270QYcna_BtNC_TbrVLwZVefYuuV85Wog3V49YqoqixAIdMdhb9Na1nPsV_RwaYfFOVsCCbQbK-D_1WTizeaQxBQ96eDsLvs8Hclf99He0TKKdxF8I0=&uniplatform=NZKPT&language=CHS
    [Google Scholar]
  37. Zhu L. Zhang S. Chen S. Wu H. Jiang M. Liu A. Exosomal miR-552-5p promotes tumorigenesis and disease progression via the PTEN/TOB1 axis in gastric cancer. J. Cancer 2022 13 3 890 905 10.7150/jca.66903 35154457
    [Google Scholar]
  38. Yan R.S. Liu H.X. Diagnostic value of circulating exosome miR-151-5p in early gastric cancer. J Clin Res 2022 39 6 831 834 https://d.wanfangdata.com.cn/periodical/hnyx202206009
    [Google Scholar]
  39. Wang XL Wang Y Song ZC Xiao JZ Song JY Cao YF Correlation between the expression of LncRNA-MIR100HG/miR-100 in exosomes and clinicopathological characteristics and progression free survival rate of gastric cancer. Prog. Mod. Biomed. 2023 23 12 2305 2357 https://link.cnki.net/doi/10.13241/j.cnki.pmb.2023.12.019
    [Google Scholar]
  40. Jin Z. Song Y. Lian C. Gao L. Decreased serum exosomal microRNA-134 expression and its prognostic value in gastric cancer. Ann. Clin. Lab. Sci. 2022 52 4 563 570 36197781
    [Google Scholar]
  41. Liu J. Li Z. Teng W. Ye X. Identification of downregulated circRNAs from tissue and plasma of patients with gastric cancer and construction of a circRNA‐miRNA‐mRNA network. J. Cell. Biochem. 2020 121 11 4590 4600 10.1002/jcb.29673 32052496
    [Google Scholar]
  42. Zhang H. Deng T. Liu R. Ning T. Yang H. Liu D. Zhang Q. Lin D. Ge S. Bai M. Wang X. Zhang L. Li H. Yang Y. Ji Z. Wang H. Ying G. Ba Y. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol. Cancer 2020 19 1 43 10.1186/s12943‑020‑01168‑8 32106859
    [Google Scholar]
  43. Yue F. Peng K. Zhang L. Zhang J. Circ_0004104 accelerates the progression of gastric cancer by regulating the miR-539-3p/RNF2 axis. Dig. Dis. Sci. 2021 66 12 4290 4301 10.1007/s10620‑020‑06802‑5 33449226
    [Google Scholar]
  44. Xia X. Wang S. Ni B. Xing S. Cao H. Zhang Z. Yu F. Zhao E. Zhao G. Hypoxic gastric cancer-derived exosomes promote progression and metastasis via MiR-301a-3p/PHD3/HIF-1α positive feedback loop. Oncogene 2020 39 39 6231 6244 10.1038/s41388‑020‑01425‑6 32826951
    [Google Scholar]
  45. Wu C. Li D. Cheng X. Gu H. Qian Y. Feng L. Downregulation of cancer-associated fibroblast exosome-derived miR-29b-1-5p restrains vasculogenic mimicry and apoptosis while accelerating migration and invasion of gastric cancer cells via immunoglobulin domain-containing 1/zonula occluden-1 axis. Cell Cycle 2023 22 17 1807 1826 10.1080/15384101.2023.2231740 37587724
    [Google Scholar]
  46. Liu C. Yang J. Zhu F. Zhao Z. Gao L. Exosomal circ_0001190 regulates the progression of gastric cancer via miR-586/SOSTDC1 axis. Biochem. Genet. 2022 60 6 1895 1913 10.1007/s10528‑021‑10180‑6 35138469
    [Google Scholar]
  47. Wang Q.X. Zhu Y.Q. Zhang H. Xiao J. Altered MiRNA expression in gastric cancer: A systematic review and meta-analysis. Cell. Physiol. Biochem. 2015 35 3 933 944 10.1159/000369750 25633747
    [Google Scholar]
  48. Ruggieri V. Russi S. Zoppoli P. La Rocca F. Angrisano T. Falco G. Calice G. Laurino S. The role of MicroRNAs in the regulation of gastric cancer stem cells: A meta-analysis of the current status. J. Clin. Med. 2019 8 5 639 10.3390/jcm8050639 31075910
    [Google Scholar]
  49. Aalami A.H. Aalami F. Sahebkar A. Gastric cancer and circulating microRNAs: An updated systematic review and diagnostic meta-analysis. Curr. Med. Chem. 2023 30 33 3798 3814 36411580
    [Google Scholar]
  50. Zare A. Ganji M. Omrani M.D. Alipoor B. Ghaedi H. Gastric cancer MicroRNAs meta-signature. Int. J. Mol. Cell. Med. 2019 8 2 94 102 32215261
    [Google Scholar]
  51. Fan H.N. Zhao X.Y. Liang R. Chen X.Y. Zhang J. Chen N.W. Zhu J.S. CircPTK2 inhibits the tumorigenesis and metastasis of gastric cancer by sponging miR-134-5p and activating CELF2/PTEN signaling. Pathol. Res. Pract. 2021 227 153615 10.1016/j.prp.2021.153615 34562827
    [Google Scholar]
  52. Cheng Z. Cheng N. Tang X. Yang F. Ma W. Yu Q. Tang H. Xiao Q. Lei Z. miR-552 promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma by targeting FOXO1. Exp. Cell Res. 2023 431 1 113741 10.1016/j.yexcr.2023.113741 37549804
    [Google Scholar]
  53. Chen J. Zheng B. Wang C. Chen Y. Du C. Zhao G. Zhou Y. Shi Y. Prognostic role of microRNA-100 in various carcinomas: Evidence from six studies. Tumour Biol. 2014 35 4 3067 3071 10.1007/s13277‑013‑1398‑3 24258109
    [Google Scholar]
  54. Huang Z.S. Guo X.W. Zhang G. Liang L.X. Nong B. The diagnostic and prognostic value of miR-200c in gastric cancer: A meta-analysis. Dis. Markers 2019 2019 1 9 10.1155/2019/8949618 31089400
    [Google Scholar]
  55. Xiao D. Xie J. Wu S. MicroRNA-182 is a potential biomarker for prognosis of gastric cancer. Medicine 2021 100 22 e25830 10.1097/MD.0000000000025830 34087825
    [Google Scholar]
  56. Xue J. Qin S. Ren N. Guo B. Shi X. Jia E. Extracellular vesicle biomarkers in circulation for the diagnosis of gastric cancer: A systematic review and meta‑analysis. Oncol. Lett. 2023 26 4 423 10.3892/ol.2023.14009 37664665
    [Google Scholar]
  57. Ren J. Kuang T.H. Chen J. Yang J.W. Liu Y.X. The diagnostic and prognostic values of microRNA-21 in patients with gastric cancer: A meta-analysis. Eur. Rev. Med. Pharmacol. Sci. 2017 21 1 120 130 28121346
    [Google Scholar]
/content/journals/cmc/10.2174/0109298673356200250612183707
Loading
Meta-analysis and Database Validation of Exosomal microRNAs and Prognosis in Gastric Cancer Patients
Bentham Science Publishers ; https://doi.org/10.2174/0109298673356200250612183707
/content/journals/cmc/10.2174/0109298673356200250612183707
/content/journals/cmc/10.2174/0109298673356200250612183707
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keywords: Prognosis ; Embase ; Gastric cancer ; meta-analysis ; microRNA ; GEO

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test